Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,387.19
(
-0.29%
)
US TECH 100
28,152.40
(
-0.72%
)
Dow Jones
49,624.11
(
0.20%
)
Brent Oil
107.56
(
0.08%
)
Bitcoin
76,129.52
(
-1.65%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Regulardoc post# 133794

Saturday, 12/24/2011 4:33:40 PM

Saturday, December 24, 2011 4:33:40 PM

Post# of 257580

Who pays for the costs of clinical trials for the first two compounds?

BAX does. For the first two FoB’s in the collaboration, MNTA pays for pre-IND process development and is reimbursed by BAX via the $91M in technical/development milestones (#msg-70258421, #msg-70234186). After the IND filing for each of the first two compounds, BAX bears all of the development and commercialization costs.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today